Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Cannabinoid receptor 1 gene (CNR1) and susceptibility to a quantitative phenotype for hebephrenic schizophrenia.

Chavarría-Siles I, Contreras-Rojas J, Hare E, Walss-Bass C, Quezada P, Dassori A, Contreras S, Medina R, Ramírez M, Salazar R, Raventos H, Escamilla MA.

Am J Med Genet B Neuropsychiatr Genet. 2008 Apr 5;147(3):279-84. doi: 10.1002/ajmg.b.30592.

PMID:
18186055
2.

CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia.

Ujike H, Takaki M, Nakata K, Tanaka Y, Takeda T, Kodama M, Fujiwara Y, Sakai A, Kuroda S.

Mol Psychiatry. 2002;7(5):515-8.

3.

No association of CNR1 gene variations with susceptibility to schizophrenia.

Seifert J, Ossege S, Emrich HM, Schneider U, Stuhrmann M.

Neurosci Lett. 2007 Oct 9;426(1):29-33. Epub 2007 Aug 10.

PMID:
17881126
4.

Association study of a cannabinoid receptor gene (CNR1) polymorphism and schizophrenia.

Tsai SJ, Wang YC, Hong CJ.

Psychiatr Genet. 2000 Sep;10(3):149-51.

PMID:
11204352
5.

(AAT)n repeat in the cannabinoid receptor gene (CNR1): association with cocaine addiction in an African-Caribbean population.

Ballon N, Leroy S, Roy C, Bourdel MC, Charles-Nicolas A, Krebs MO, Poirier MF.

Pharmacogenomics J. 2006 Mar-Apr;6(2):126-30.

PMID:
16314880
6.

Association study of cannabinoid receptor gene (CNR1) alleles and anorexia nervosa: differences between restricting and binging/purging subtypes.

Siegfried Z, Kanyas K, Latzer Y, Karni O, Bloch M, Lerer B, Berry EM.

Am J Med Genet B Neuropsychiatr Genet. 2004 Feb 15;125B(1):126-30.

PMID:
14755457
7.

Human cannabinoid receptor 1: 5' exons, candidate regulatory regions, polymorphisms, haplotypes and association with polysubstance abuse.

Zhang PW, Ishiguro H, Ohtsuki T, Hess J, Carillo F, Walther D, Onaivi ES, Arinami T, Uhl GR.

Mol Psychiatry. 2004 Oct;9(10):916-31.

PMID:
15289816
8.

The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain.

Ramil E, Sánchez AJ, González-Pérez P, Rodríguez-Antigüedad A, Gómez-Lozano N, Ortiz P, Arroyo R, De las Heras V, Vilches C, García-Merino A.

Mult Scler. 2010 Feb;16(2):139-46. doi: 10.1177/1352458509355071. Epub 2009 Dec 9.

PMID:
20007426
9.

The CNR1 gene as a pharmacogenetic factor for antipsychotics rather than a susceptibility gene for schizophrenia.

Hamdani N, Tabeze JP, Ramoz N, Ades J, Hamon M, Sarfati Y, Boni C, Gorwood P.

Eur Neuropsychopharmacol. 2008 Jan;18(1):34-40. Epub 2007 Jul 31.

PMID:
17669634
10.

Cannabinoid receptor 1 gene polymorphism and irritable bowel syndrome in the Korean population: a hypothesis-generating study.

Park JM, Choi MG, Cho YK, Lee IS, Kim SW, Choi KY, Chung IS.

J Clin Gastroenterol. 2011 Jan;45(1):45-9. doi: 10.1097/MCG.0b013e3181dd1573.

PMID:
20505532
11.

Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential.

Stadelmann AM, Juckel G, Arning L, Gallinat J, Epplen JT, Roser P.

Neurosci Lett. 2011 May 27;496(1):60-4. doi: 10.1016/j.neulet.2011.04.003. Epub 2011 Apr 12.

PMID:
21513772
12.

Variations in the cannabinoid receptor 1 gene predispose to migraine.

Juhasz G, Lazary J, Chase D, Pegg E, Downey D, Toth ZG, Stones K, Platt H, Mekli K, Payton A, Anderson IM, Deakin JF, Bagdy G.

Neurosci Lett. 2009 Sep 18;461(2):116-20. doi: 10.1016/j.neulet.2009.06.021. Epub 2009 Jun 17.

PMID:
19539700
13.

[Endocannabinoid system and CNR1 gene polymorphisms in schizophrenia and addictive disorders].

Martínez-Gras I, Hoecnika J, Pérez-Hernández E, Rodríguez-Jiménez R, Ponce G, Jiménez-Arriero M, Ramos-Atance J, Palomo T, Rubio G.

Actas Esp Psiquiatr. 2007 Mar-Apr;35(2):122-9. Review. Spanish.

PMID:
17401783
14.

Depression in Parkinson's disease is related to a genetic polymorphism of the cannabinoid receptor gene (CNR1).

Barrero FJ, Ampuero I, Morales B, Vives F, de Dios Luna Del Castillo J, Hoenicka J, García Yébenes J.

Pharmacogenomics J. 2005;5(2):135-41.

PMID:
15668727
15.

Tourette syndrome is not caused by mutations in the central cannabinoid receptor (CNR1) gene.

Gadzicki D, Müller-Vahl KR, Heller D, Ossege S, Nöthen MM, Hebebrand J, Stuhrmann M.

Am J Med Genet B Neuropsychiatr Genet. 2004 May 15;127B(1):97-103.

PMID:
15108190
16.

Association study of cannabinoid receptor 1 (CNR1) gene in tardive dyskinesia.

Tiwari AK, Zai CC, Likhodi O, Voineskos AN, Meltzer HY, Lieberman JA, Potkin SG, Remington G, Müller DJ, Kennedy JL.

Pharmacogenomics J. 2012 Jun;12(3):260-6. doi: 10.1038/tpj.2010.93. Epub 2011 Jan 25.

PMID:
21266946
17.

Single nucleotide change in the cannabinoid receptor-1 (CNR1) gene in colorectal cancer outcome.

Bedoya F, Rubio JC, Morales-Gutierrez C, Abad-Barahona A, Lora Pablos D, Meneu JC, Moreno-Gonzalez E, Enriquez de Salamanca R, Vegh I.

Oncology. 2009;76(6):435-41. doi: 10.1159/000217263. Epub 2009 May 5.

PMID:
19420965
18.
19.

(AAT)n repeat in the cannabinoid receptor gene, CNR1: association with schizophrenia in a Spanish population.

Martínez-Gras I, Hoenicka J, Ponce G, Rodríguez-Jiménez R, Jiménez-Arriero MA, Pérez-Hernandez E, Ampuero I, Ramos-Atance JA, Palomo T, Rubio G.

Eur Arch Psychiatry Clin Neurosci. 2006 Oct;256(7):437-41. Epub 2006 Jun 20.

PMID:
16788767
20.

Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean population.

Bae JS, Kim JY, Park BL, Kim JH, Kim B, Park CS, Kim BJ, Lee CS, Lee M, Choi WH, Shin TM, Hwang J, Shin HD, Woo SI.

Psychiatr Genet. 2014 Oct;24(5):225-9. doi: 10.1097/YPG.0000000000000047.

PMID:
25014618

Supplemental Content

Support Center